Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Serum parathyroid hormone (PTH) levels were higher on a regular diet at baseline in Npt2b−/− mice than in Npt2b+/+ mice (Fig. 6g), and tended to be higher in PAM patients than healthy controls (Fig. 6h), but there were no other significant baseline differences from cognate controls in NPT2B deficient mice or humans in serum fibroblast growth factor 23 (FGF-23) (Figs. 6i, j), 1,25-dihydroxyvitamin D (VitD3) (Fig. 6k, l), phosphate (Fig. 6m, n) or calcium (Fig. 6o, p).

Source: Low-phosphate diet reverses microlith accumulation in PAM model mice. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The epithelium-targeted Npt2b−/− mouse model was developed by breeding mice homozygous for floxed Slc34a2 with mice expressing Cre recombinase under the influence of the sonic hedgehog (Shh) promoter, as previously reported.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Insights into pulmonary phosphate homeostasis and osteoclastogenesis emerge from the study of pulmonary alveolar microlithiasis

Study design awaiting verification · Nature Communications · 2023

Original publication title

Insights into pulmonary phosphate homeostasis and osteoclastogenesis emerge from the study of pulmonary alveolar microlithiasis

Yasuaki Uehara; Yusuke Tanaka; Shuyang Zhao; Nikolaos M. Nikolaidis; Lori B. Pitstick; Huixing Wu; Jane J. Yu; Erik Zhang; Yoshihiro Hasegawa; John G. Noel; Jason C. Gardner; Elizabeth J. Kopras; Wendy D. Haffey; Kenneth D. Greis; Jinbang Guo; Jason C. Woods; Kathryn A. Wikenheiser-Brokamp; Jennifer E. Kyle; Charles Ansong; Steven L. Teitelbaum; Yoshikazu Inoue; Göksel Altinişik; Yan Xu; Francis X. McCormack

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Pulmonary alveolar microlithiasis is an autosomal recessive lung disease caused by a deficiency in the pulmonary epithelial Npt2b sodium-phosphate co-transporter that results in accumulation of phosphate and formation of hydroxyapatite microliths in the alveolar space. The single cell transcriptomic analysis of a pulmonary alveolar microlithiasis lung explant showing a robust osteoclast gene signature in alveolar monocytes and the finding that calcium phosphate microliths contain a rich protein and lipid matrix that includes bone resorbing osteoclast enzymes and other proteins suggested a role for osteoclast-like cells in the host response to microliths.

While investigating the mechanisms of microlith clearance, we found that Npt2b modulates pulmonary phosphate homeostasis through effects on alternative phosphate transporter activity and alveolar osteoprotegerin, and that microliths induce osteoclast formation and activation in a receptor activator of nuclear factor-κB ligand and dietary phosphate dependent manner. This work reveals that Npt2b and pulmonary osteoclast-like cells play key roles in pulmonary homeostasis and suggest potential new therapeutic targets for the treatment of lung disease.

Osteoclasts are derived from circulating myeloid cells to mediate bone repair, maintenance and remodeling. Here, the authors show that the lung also recruits and reprograms monocytes and alveolar macrophages into osteoclast-like cells to clear pathogenic particles from the airspace.

Authors’ abstract

Pulmonary alveolar microlithiasis is an autosomal recessive lung disease caused by a deficiency in the pulmonary epithelial Npt2b sodium-phosphate co-transporter that results in accumulation of phosphate and formation of hydroxyapatite microliths in the alveolar space. The single cell transcriptomic analysis of a pulmonary alveolar microlithiasis lung explant showing a robust osteoclast gene signature in alveolar monocytes and the finding that calcium phosphate microliths contain a rich protein and lipid matrix that includes bone resorbing osteoclast enzymes and other proteins suggested a role for osteoclast-like cells in the host response to microliths.

While investigating the mechanisms of microlith clearance, we found that Npt2b modulates pulmonary phosphate homeostasis through effects on alternative phosphate transporter activity and alveolar osteoprotegerin, and that microliths induce osteoclast formation and activation in a receptor activator of nuclear factor-κB ligand and dietary phosphate dependent manner. This work reveals that Npt2b and pulmonary osteoclast-like cells play key roles in pulmonary homeostasis and suggest potential new therapeutic targets for the treatment of lung disease.

Osteoclasts are derived from circulating myeloid cells to mediate bone repair, maintenance and remodeling. Here, the authors show that the lung also recruits and reprograms monocytes and alveolar macrophages into osteoclast-like cells to clear pathogenic particles from the airspace.

Publication and source details

Original title: Insights into pulmonary phosphate homeostasis and osteoclastogenesis emerge from the study of pulmonary alveolar microlithiasis

Yasuaki Uehara; Yusuke Tanaka; Shuyang Zhao; Nikolaos M. Nikolaidis; Lori B. Pitstick; Huixing Wu; Jane J. Yu; Erik Zhang; Yoshihiro Hasegawa; John G. Noel; Jason C. Gardner; Elizabeth J. Kopras; Wendy D. Haffey; Kenneth D. Greis; Jinbang Guo; Jason C. Woods; Kathryn A. Wikenheiser-Brokamp; Jennifer E. Kyle; Charles Ansong; Steven L. Teitelbaum; Yoshikazu Inoue; Göksel Altinişik; Yan Xu; Francis X. McCormack

Nature Communications · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/100000002U.S. Department of Health & Human Services | National Institutes of Health (NIH)R37AR046523R01DK111389Teitelbaum Steven L. U.S. Department of Health & Human Services | National Institutes of Health (NIH)https://doi.org/10.13039/100000050U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)R01HL127455McCormack Francis X.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:16:18.374212+00:00

DOI: 10.1038/s41467-023-36810-8 · PMC9981730